Page 134 of 136 for 'ITC litigation' in ITC litigation

Filters

Result types

Showing 1331 - 1340 of 1356 for "ITC litigation" with applied filters

Filters:

Move The Needle Fund: a data-driven diversity project in law

19 September 2019 by Kingsley Egbuonu

Diversity Lab is looking for a law firm to become one the sponsors/founders of its innovative diversity and inclusion project

News & Analysis

IP people moves and firm announcements: Europe and Americas

05 September 2019 by Kingsley Egbuonu

Dentons, Stibbe, Bardehle Pagenberg, Rouse, Hogan Lovells, Antequera Parilli & Rodríguez, Eversheds Sutherland, and Lewis Silkin made firm announcements in the past few months

News & Analysis

Milbank welcomes four IP litigators in Los Angeles

17 August 2019 by Chris Adams and Kingsley Egbuonu

The firm hired four IP litigators, two of whom are ranked as patent stars, from a rival

News & Analysis

Patents for etanercept valid, says court

16 August 2019 by Chris Adams and Kingsley Egbuonu

In a highly-anticipated biologic patent dispute, the US District Court for the District of New Jersey has found that Amgen's patents for Enbrel® (etanercept) are valid. Two ranked firms are involved in this dispute

News & Analysis

Apple to buy Intel’s smartphone modem business

02 August 2019 by Kingsley Egbuonu

The $1 billion transaction will see Apple acquire “innovative” wireless technology patents from Intel

News & Analysis

Developing the future leaders in IP

01 August 2019 by Kingsley Egbuonu

In an article published in the July/August issue of Managing IP magazine, Nicola Dagg, Daniel Lim and Katie Coltart of Kirkland & Ellis talked about the challenges firms face to develop and retain young, talented lawyers and the benefits of an empowering working culture

News & Analysis

Austrian IP boutique ceases to exist

17 July 2019 by Kingsley Egbuonu

The firm's name partners decided to go their separate ways, with one opting to join a general law firm

News & Analysis

Proposed BPCIA reforms: More music, same dance

16 May 2019 by Paul A Ainsworth and Lauren A Watt

Paul A Ainsworth and Lauren A Watt of Sterne Kessler Goldstein & Fox examine the extent to which the proposed Biologic Patent Transparency Act will reduce patent thickets, increase transparency and competition in the biologics industry.

News & Analysis